(Boursier.com) — By letter received on November 23 by the AMF, the simplified joint stock company Sofinnova Partners, acting on behalf of the Sofinnova Crossover I SLP fund which it manages, declared having crossed upward on the 21 November, the thresholds of 20% of the capital and voting rights of GenSight and hold, on behalf of the said fund, 13,260,067 shares representing as many voting rights, or 20.30% of the capital and voting rights. This crossing of thresholds results from the subscription to a capital increase of the company GenSight. The declarant indicated that it did not plan to carry out any GenSight actions, but that it planned to continue supporting the company in the clinical development of its products with a view to their marketing and in research new sources of financing in debt or equity or partnership or M&A operations.
©2023 Boursier.com